We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Studio Pictures Ltd is a UK-based film and TV production company founded by producers Adam Rolston and David Braithwaite in 2019. Specializing in creating high-quality British entertainment content, the company focuses on adapting books to screen and telling unique true-life stories that entertain and inspire both domestic and international audiences. With successful productions like "A Street Cat Named Bob," the company is building a strong brand and reputation in the industry. Studio Pictures has access to top creative talent and collaborates with major studios like Warner Bros, Sony Pictures, Lionsgate, and Studio Canal. The company is located at Twickenham Studios in Richmond, UK.
days to go: 18 investment: Withheld
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go: Extended investment: Withheld
A taxi and on-demand delivery service using electronically assisted, high-tech cargo bikes to offer a cleaner, faster and cheaper means of transportation. Pedal Me uses highly trained riders within London to carry almost any load, including two adults, which can all be booked through their app. Between October 2017 and September 2018, Pedal Me generated revenues of more than £125k. They will be allocating investments towards increasing efficiency and improving pickup times. Funds in this round will be used to add more bikes, riders and use smarter technology. Pedal Me aims to have more than 30 bikes within a 3-mile radius from the city centre. This will result in reducing pickup times to less than 8 minutes from a booking being placed. In addition, the company will 'stack' delivery jobs, which means one rider will be able to carry out multiple orders in a single journey and will therefore allow Pedal Me to keep prices down for customers. Future plans include expanding the service to the rest of the UK and overseas.
days to go: Expired investment: £352,580
Percuro is a low carbon, next-generation pet food that is ethically farmed and formulated using insect proteins. The company argues that its pet food has a low carbon pawprint whilst being hypoallergenic and nutritious with low inflammation properties. Percuro has launched its Direct-To-Consumer (DTC) site in the UK and Germany with a roll-out plan that includes covering additional EU markets later in 2021, raised a £340,000 seed investment in the previous 10 months, and signed product listing agreements with key retailers in the UK and Singapore. The company will use 40% of the investment for brand building through digital marketing, 30% for retailer brand-building investments, 20% towards launching treats and its plant dog range, and 10% towards new market expansion into Asia.

Pitch Rated

47%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £618,596
Rightangled is a healthcare technology company backed by NHS England & regulated by the Care Quality Commission (CQC). It began its journey as a platform that would enable the use of genetic information within the medical practice, in an accurate, streamlined, and affordable way. It gradually established itself as a healthcare provider for screening and diagnostic services. Its Heart DNA Test project, launched in 2017, is helping patients minimize their cardiac risks and enabling doctors to have a complete risk profile for their patients. The project was appreciated and received funding from NHS England. Its next project, Fitness DNA Test, tapped into the fitness and wellbeing markets. Recently, in the wake of the COVID-19 threat, the company has developed a home-based throat swab test to detect the viral infection, by testing viral load presented in its nucleic acid material within (RNA). For its efforts, Rightangled has been featured on CNN, Sky News, LBC radio, Sky News radio, and Newsweek. With the investment, the company aims to release a mobile application by the end of 2020, and develop an AI system to give instant tailored health, diet, and fitness advice to its users based on the data gathered from patient-doctor interactions and patient responses.

Pitch Rated

81%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £522,689
Techsixtyfour is wholesalers of watches and jewellery, and My Gator Watch is a part of it. My Gator Watch sells one of the UK's high-rating wearable mobile phone and tracker for children. It is an award-winning technology brand, selling essentially on Amazon and have sold over 2300 watches. In 2018, the AXA team chose My Gator Watch as the winning product as it met the requirements of the elderly. To expand into the elderly market, My Gator Watch has planned to raise the fund. With the proceeds, apart from creating a new website and brand for the elderly market, it is planning to develop new accessories /features to increase marketing for both the markets.
days to go: Expired investment: £61,820
Hope is an online fashion brand that targets the 50+ woman demographic. Founded in 2015 by Nayna McIntosh, who has more than 30 years of experience in the fashion industry, the company has 34,000 subscribers and 6,300 customers. The brand is 'Made in Italy' or 'Made in UK' using recycled cashmere and 100% recyclable packaging. Hope has 1600+ reviews on Trustpilot and has been featured in The Sunday Telegraph/Woman & Home and The Telegraph Magazine. With the proceeds, the company will invest in digital advertising and web development.

Pitch Rated

64%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £268,312
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph